{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:51Z","timestamp":1759104171781,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vetimm.2022.110497","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:10:43Z","timestamp":1664197843000},"page":"110497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating the Immunogenicity of recombinant VP1 protein from the foot-and-mouth disease virus encapsulated in nanoliposome in guinea pig animal model"],"prefix":"10.1016","volume":"253","author":[{"given":"Marjan","family":"Kazemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud Reza","family":"Aghamaali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasool","family":"Madani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Emami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Golchinfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1099\/0022-1317-83-4-775","article-title":"Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species","volume":"83","author":"Aggarwal","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1099\/0022-1317-83-4-775","article-title":"Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species","volume":"83","author":"Aggarwal","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","article-title":"The pathogenesis and diagnosis of foot-and-mouth disease","volume":"129","author":"Alexandersen","year":"2003","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.vetimm.2022.110497_bib4","first-page":"35451","article-title":"The foot-and-mouth disease situation in Iran","author":"Arshadi","year":"1976","journal-title":"Dev. Biol. Stand"},{"issue":"23","key":"10.1016\/j.vetimm.2022.110497_bib5","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1016\/j.vaccine.2020.04.006","article-title":"Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates","volume":"38","author":"Avenda\u00f1o","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vetimm.2022.110497_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.115.6.1636","article-title":"Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus","volume":"115","author":"Bachrach","year":"1975","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.vetimm.2022.110497_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-70-6-1483","article-title":"Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites","volume":"70","author":"Barnett","year":"1989","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.vetimm.2022.110497_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(91)90261-4","article-title":"Developments in foot-and-mouth disease vaccines","volume":"9","author":"Barteling","year":"1991","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vetimm.2022.110497_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vetimm.2004.12.008","article-title":"A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses","volume":"104","author":"Beignon","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"23","key":"10.1016\/j.vetimm.2022.110497_bib10","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/S0264-410X(03)00251-2","article-title":"Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents","volume":"21","author":"Ben-Yehuda","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2022.110497_bib11","first-page":"78104105","article-title":"Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure","author":"Biswal","year":"2020","journal-title":"Infect. Genet Evol."},{"issue":"5869","key":"10.1016\/j.vetimm.2022.110497_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/298030a0","article-title":"Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence","volume":"298","author":"Bittle","year":"1982","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/08828240151061383","article-title":"Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants","volume":"14","author":"Carrillo","year":"2001","journal-title":"Viral Immunol."},{"issue":"2","key":"10.1016\/j.vetimm.2022.110497_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/jvi.48.2.451-459.1983","article-title":"Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus","volume":"48","author":"Cheung","year":"1983","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2022.110497_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2004.08.012","article-title":"Foot-and-mouth disease: the vital need for collaboration as an aid to disease elimination","author":"Crispin","year":"2005","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2022.110497_bib17","first-page":"318256","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","author":"Crommelin","year":"2020","journal-title":"J. Control Release"},{"issue":"8","key":"10.1016\/j.vetimm.2022.110497_bib18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1099\/0022-1317-74-8-1547","article-title":"Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants","volume":"74","author":"Crowther","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.vetimm.2022.110497_bib19","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/jvi.71.12.9743-9752.1997","article-title":"Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus","volume":"71","author":"Curry","year":"1997","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12951-017-0319-9","article-title":"Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines","volume":"15","author":"De Serrano","year":"2017","journal-title":"J. Nanobiotechnol."},{"issue":"18","key":"10.1016\/j.vetimm.2022.110497_bib21","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1073\/pnas.85.18.6811","article-title":"Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution","volume":"85","author":"DoPAZO","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib22","first-page":"1","article-title":"Liposome and polymer-based nanomaterials for vaccine applications","volume":"6","author":"Evelyn Roopngam","year":"2019","journal-title":"Nanomed. J."},{"key":"10.1016\/j.vetimm.2022.110497_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1099\/0022-1317-77-4-727","article-title":"Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes","volume":"77","author":"Garcia-Valcarcel","year":"1996","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1039\/C3SM50947H","article-title":"Formation of supported lipid bilayers on silica: relation to lipid phase transition temperature and liposome size","volume":"10","author":"Jing","year":"2014","journal-title":"Soft Matter"},{"issue":"7","key":"10.1016\/j.vetimm.2022.110497_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10295-013-1273-7","article-title":"High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli","volume":"40","author":"Jung","year":"2013","journal-title":"J. Ind. Microbiol Biotechnol."},{"key":"10.1016\/j.vetimm.2022.110497_bib27","first-page":"12205","article-title":"Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives","author":"Kenubih","year":"2021","journal-title":"Vet. Med.: Res. Rep."},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02703901","article-title":"Liposomes in immunology","volume":"6","author":"Latif","year":"1984","journal-title":"J. Biosci."},{"issue":"7\u20138","key":"10.1016\/j.vetimm.2022.110497_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0264-410X(00)00217-6","article-title":"A comparison of two commercial recombinant vaccines for hepatitis B in adolescents","volume":"19","author":"Leroux-Roels","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2022.110497_bib30","first-page":"1551532","article-title":"Soluble FMDV VP1 proteins fused with calreticulin expressed in Escherichia coli under the assist of trigger factor16 (Tf16) formed into high immunogenic polymers","author":"Liu","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.vetimm.2022.110497_bib31","first-page":"2017","article-title":"Expression and immunogenicity of two recombinant fusion proteins comprising foot-and-mouth disease virus structural protein VP1 and DC-SIGN-binding glycoproteins","author":"Liu","year":"2017","journal-title":"Biomed. Res Int"},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13568-019-0938-7","article-title":"Production of foot-and-mouth disease virus SAT2 VP1 protein","volume":"10","author":"Mamabolo","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.vetimm.2022.110497_bib33","series-title":"Liposomes as a vaccine delivery system. Micro and Nanotechnology in vaccine Development","first-page":"221","author":"Marasini","year":"2017"},{"journal-title":"Cloning Expr. FMDV-VP1 immunoreactive Pept. trivalent Form. its Appl. immunogen","year":"2008","author":"Nagarajan","key":"10.1016\/j.vetimm.2022.110497_bib34"},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib35","first-page":"235","article-title":"Expression and detection of the FMDV VP1 transgene and expressed structural protein in Arabidopsis thaliana","volume":"35","author":"Pan","year":"2011","journal-title":"Turk. J. Vet. Anim. Sci."},{"issue":"8","key":"10.1016\/j.vetimm.2022.110497_bib36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2005.09.006","article-title":"Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance","volume":"24","author":"Parida","year":"2006","journal-title":"Vaccine"},{"issue":"6293","key":"10.1016\/j.vetimm.2022.110497_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/347569a0","article-title":"Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus","volume":"347","author":"Parry","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2022.110497_bib38","first-page":"2885","article-title":"Understanding the transmission of foot-and-mouth disease virus at different scales","author":"Paton","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"6","key":"10.1016\/j.vetimm.2022.110497_bib39","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1128\/jvi.62.6.2033-2040.1988","article-title":"Analysis of neutralizing epitopes on foot-and-mouth disease virus","volume":"62","author":"Pfaff","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2022.110497_bib40","unstructured":"Policy, I. IACUC Policy on Administering Complete Freund\u2019s Adjuvant (CFA) and other Adjuvants, 2022."},{"issue":"3","key":"10.1016\/j.vetimm.2022.110497_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2011.05.005","article-title":"Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan","volume":"153","author":"Riviere","year":"2011","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.vetimm.2022.110497_bib42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.20506\/rst.21.3.1378","article-title":"Global perspective for foot and mouth disease control","volume":"21","author":"Rweyemamu","year":"2002","journal-title":"REV SCI TECH OIE"},{"issue":"5","key":"10.1016\/j.vetimm.2022.110497_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.vaccine.2014.12.008","article-title":"Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle","volume":"33","author":"Saravanan","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vetimm.2022.110497_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther. Adv. Vaccin."},{"issue":"3","key":"10.1016\/j.vetimm.2022.110497_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3923\/javaa.2012.426.430","article-title":"Cloning of structural protein VP1 gene of foot and mouth disease virus and its expression in Escherichia coli","volume":"11","author":"Shi","year":"2012","journal-title":"J. Anim. Vet. Adv."},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2001106","article-title":"Foot-and-mouth disease virus: a long known virus, but a current threat","volume":"32","author":"Sobrino","year":"2001","journal-title":"Vet. Res"},{"issue":"1","key":"10.1016\/j.vetimm.2022.110497_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.vetimm.2022.110497_bib48","first-page":"561","article-title":"Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity","volume":"44","author":"Van Houte","year":"1981","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.vetimm.2022.110497_bib49","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/j.1460-2075.1995.tb07158.x","article-title":"Structure of the major antigenic loop of foot\u2010and\u2010mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg\u2010Gly\u2010Asp motif in the interaction","volume":"14","author":"Verdaguer","year":"1995","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.vetimm.2022.110497_bib50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0003-2697(75)90363-2","article-title":"Lowry determination of protein in the presence of Triton X-100","volume":"63","author":"Wang","year":"1975","journal-title":"Anal. Biochem."},{"issue":"25\u201326","key":"10.1016\/j.vetimm.2022.110497_bib51","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/S0264-410X(03)00363-3","article-title":"Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus","volume":"21","author":"Wang","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vetimm.2022.110497_bib52","article-title":"Protection against foot-and-mouth disease virus in guinea pigs via oral administration of recombinant Lactobacillus plantarum expressing VP1","volume":"10","author":"Wang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vetimm.2022.110497_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01449","article-title":"Adenovirus-Vectored Capsid Proteins of the Serotype A Foot-and-Mouth Disease Virus Protect Guinea Pigs Against Challenge","author":"Xie","year":"2020","journal-title":"Front Microbiol"},{"issue":"26","key":"10.1016\/j.vetimm.2022.110497_bib54","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.vaccine.2018.05.045","article-title":"Genetic and antigenic relationship of foot\u2013and\u2013mouth disease virus serotype O isolates with the vaccine strain O1\/BFS","volume":"36","author":"Xu","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vetimm.2022.110497_bib55","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1073\/pnas.74.3.1234","article-title":"Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition","volume":"74","author":"Yasuda","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.vetimm.2022.110497_bib56","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00253-019-10280-9","article-title":"Engineering viable foot-and-mouth disease viruses with increased acid stability facilitate the development of improved vaccines","volume":"104","author":"Yuan","year":"2020","journal-title":"Appl. Microbiol Biotechnol."},{"key":"10.1016\/j.vetimm.2022.110497_bib57","first-page":"305194","article-title":"Liposome and immune system interplay: Challenges and potentials","author":"Zahednezhad","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.vetimm.2022.110497_bib58","first-page":"142104061","article-title":"Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine","author":"Zheng","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vetimm.2022.110497_bib59","first-page":"142104061","article-title":"Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine","author":"Zheng","year":"2020","journal-title":"Micro Pathog."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242722001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242722001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:29:37Z","timestamp":1759044577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242722001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":59,"alternative-id":["S0165242722001179"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2022.110497","relation":{},"ISSN":["0165-2427"],"issn-type":[{"type":"print","value":"0165-2427"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Immunogenicity of recombinant VP1 protein from the foot-and-mouth disease virus encapsulated in nanoliposome in guinea pig animal model","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2022.110497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110497"}}